WHAT’S NEW
Novel biomarkers are needed in the prognosis and treatment process of
the disease. There has been no report about thiol levels in lung
tuberculosis patients, so far. To our knowledge, this study is the first
study that investigates thiols and thiol/disulphide homeostasis in
patients with lung tuberculosis. For this purpose, determination of
dynamic thiol/disulphide status in diseases where oxidative stress plays
a major role in pathogenesis would be important.